These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3108565)

  • 1. [Experience with the use of nitroderm--a prolonged-action nitroglycerin preparation].
    Mikunis RI; Monastyrskiĭ IuI; Zhebel' VN; Serkova VK; Bogach NT
    Kardiologiia; 1987 Mar; 27(3):99-101. PubMed ID: 3108565
    [No Abstract]   [Full Text] [Related]  

  • 2. Peripheral hemodynamic effects of oral controlled-release nitroglycerin (Nitrong) in man.
    Hirshleifer I
    Curr Ther Res Clin Exp; 1973 Apr; 15(4):158-64. PubMed ID: 4633276
    [No Abstract]   [Full Text] [Related]  

  • 3. [Nitrozell retard in the light of effort tolerance tests on cyclo-ergometer in patients with stable angina pectoris].
    Poprawski K; Dylewicz P; Pelowska J; Wierzchowiecki M; Głuszek J
    Kardiol Pol; 1977; 20(6):471-8. PubMed ID: 415169
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of nitroglycerin-TTS and long-acting nitroglycerin tablets in the treatment of angina pectoris: a double-blind controlled study.
    Karlson BW; Henning R
    Clin Cardiol; 1987 Oct; 10(10):573-7. PubMed ID: 3117467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiologic assessment of the hemodynamic effects of sustained release nitroglycerin in patients with angina pectoris.
    Thompson EJ; Glass P; Torres C; Arora J; Piccone VA
    Angiology; 1973 Sep; 24(8):508-14. PubMed ID: 4199545
    [No Abstract]   [Full Text] [Related]  

  • 6. Transdermal nitroglycerin (Transiderm-Nitro) in the treatment of unstable angina pectoris.
    Dahlstrøm CG; Rasmussen K; Bagger JP; Henningsen P; Haghfelt T
    Dan Med Bull; 1986 Oct; 33(5):265-7. PubMed ID: 3096643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Duration of the hemodynamic effect of various doses of delayed-action nitroglycerin preparations].
    Savvateev KL; Metelitsa VI; Vygodin VA
    Kardiologiia; 1983 Feb; 23(2):55-61. PubMed ID: 6405071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Monotherapy of patients with stenocardia with individually administered doses of delayed-action nitrates (Working Group for Cooperative Studies on Anti-anginal Drugs)].
    Ter Arkh; 1988; 60(8):17-21. PubMed ID: 3147544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anti-anginal and hemodynamic effects of single doses of propranolol, verapamil and nitroglycerin-depot in patients with stenocardia].
    Manak NA; Prokopchuk VP; Laziuk DG
    Kardiologiia; 1988 Mar; 28(3):57-60. PubMed ID: 3132571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroglycerin ointment: a review.
    Francis GS; Hagan AD
    Angiology; 1977 Dec; 28(12):873-8. PubMed ID: 414640
    [No Abstract]   [Full Text] [Related]  

  • 11. [The rational use of nitroglycerin in delayed-action form in angina pectoris].
    Winsor T
    Munch Med Wochenschr; 1973 Jun; 115(24):1145-7. PubMed ID: 4200224
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nitrite therapy of stenocardia].
    Meesmann W; Amann L
    Dtsch Med Wochenschr; 1971 Sep; 96(36):1444-9. PubMed ID: 4397998
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effectiveness of 2 drug forms of nitroglycerin--transdermal (preparation Nitroderm-TTS) and gingival application (preparation Trinitrolong)--in ischemic heart disease patients].
    Metelitsa VI; Martsevich SIu; Piotrovskiĭ VK; Riabokon' OS; Blagodatskikh SV
    Ter Arkh; 1986; 58(6):58-62. PubMed ID: 3094187
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relation of the anti-anginal effect of nitroglycerin and its blood level in patients with stable exertion-induced stenocardia].
    Metelitsa VI; Martsevich SIu; Blagodatskikh SV; Piotrovskiĭ VK; Riabokon' OS
    Kardiologiia; 1988 Oct; 28(10):10-4. PubMed ID: 3147338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ergometric study of the duration of action of a delayed-action trinitrine in angina pectoris patients].
    Biour M; Yvenou L; Khireddine M; Gluck C; Parier JL; Cheymol G
    Therapie; 1988; 43(1):45-9. PubMed ID: 3128886
    [No Abstract]   [Full Text] [Related]  

  • 16. [A trial of the use of the transdermal preparation Deponit for treating stenocardia].
    Alliluev IG; Pecherskaia MB; Poltavskaia MG; Syrkin AL
    Ter Arkh; 1996; 68(6):55-8. PubMed ID: 8771688
    [No Abstract]   [Full Text] [Related]  

  • 17. [An analysis of the concentration-effect relation of glyceryl trinitrate in patients with stenocardia of effort after its single use in prolonged-release drug forms].
    Blagodatskikh SV; Piotrovskiĭ VK; Metelitsa VI; Martsevich SIu; Riabokon' OS
    Farmakol Toksikol; 1989; 52(5):77-81. PubMed ID: 2513227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of placebo and sustained-release nitroglycerin in anginal subjects. Preliminary report.
    Wendkos MH; Meshulam N
    J Clin Pharmacol New Drugs; 1973 Apr; 13(4):160-6. PubMed ID: 4632473
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of nitroglycerin-retard on central and peripheral hemodynamics, microcirculation and hemostasis].
    Solov'eva FV; Kirichenko LL; Smirnov VV; Kurakina TI; Shchadrintseva MI
    Sov Med; 1987; (8):3-5. PubMed ID: 3122332
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparison of the effects of depot peroral and transdermal administration of nitrate preparations].
    Camek R; Karetová D; Bultas J; Krupicka P; Boudĭk F; Fabian E
    Vnitr Lek; 1988 Feb; 34(2):122-9. PubMed ID: 3129873
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.